The company had a one-time exceptional loss of Rs 260.64 crore in the quarter ended March 2020, the filing said.
For the fiscal ended March 2020, the net profit of the company was at Rs 3,764.93 crore as against Rs 2,665.42 crore in the previous fiscal, Sun Pharma said.
ALSO READ: First Covid-19 vaccine to reach phase-1 trial is safe, say researchers
The revenue from operations for the fiscal ended March this year stood at Rs 32,837.50 crore. It was Rs 29,065.91 crore the year-ago fiscal, it added.
The board has recommended payment of dividend of Re 1 per equity share of Re 1 each for the year ended March 31, 2020, Sun Pharma said.
Shares of Sun Pharmaceutical Industries were closed at Rs 450.55 per scrip on the BSE, down1.85 per cent from its previous close.